SoCal.Startups is building the most comprehensive resource for Southern California's tech scene.
SoCal.Startups
Be an early user
Model Medicines, Inc. hero photo
Model Medicines, Inc. logo

Model Medicines, Inc.

La Jolla, CA · Founded 2019
LAST FUNDING
$15.7M
Series A

Model Medicines engineers first-in-class small molecules against biological choke points, using AI to advance pipeline-in-a-pill therapeutics across high-impact diseases.

Funding history

RoundAmount
Series A$15.7M
SEC Form D filed
Nov 14, 2025·Oct 15, 2024·Feb 7, 2024·Nov 9, 2021

About Model Medicines, Inc.

How much funding has Model Medicines, Inc. raised?

Model Medicines, Inc. has raised $15.7M in total funding. The most recent round was Series A.

Where is Model Medicines, Inc. headquartered?

Model Medicines, Inc. is headquartered in La Jolla, CA.

What does Model Medicines, Inc. do?

Model Medicines engineers first-in-class small molecules against biological choke points, using AI to advance pipeline-in-a-pill therapeutics across high-impact diseases.

What problem does Model Medicines, Inc. solve?

Many diseases (including the 'triple threat' of RSV, flu, and COVID-19, plus various cancers and other conditions) lack effective, broad-acting small-molecule drugs that hit their core underlying biological drivers.

What's Model Medicines, Inc.'s solution?

Model Medicines uses an AI-driven end-to-end engine to design, discover, and develop first-in-class small molecules that target shared biological 'choke points' (such as RdRp Thumb-1 and BRD4) underlying multiple diseases.

What makes Model Medicines, Inc. different?

Its lead candidate MDL-001 is described by outside researchers as an orally available, direct-acting, broad-spectrum antiviral showing multi-log viral load reductions across multiple viral families, an effect the page says no prior oral antiviral has demonstrated.

What makes Model Medicines, Inc. notable?

Model Medicines, an AI-first drug discovery platform, was founded by Daniel Haders II, PhD, who presented the company at the 2026 BIO Investment & Growth Summit.

Leadership

Marlon Evans
Executive Officer, Director
Executive Officer, Director
LinkedIn ↗
Kip Quackenbush
Executive Officer, Director
Industry
Healthcare
Founded
2019
HQ
La Jolla, CA
Raised
$15.7M
Stage
Series A

Related terms

❝ Cite this page

Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.

MLA
"Model Medicines, Inc.: Funding & Investors." SoCal.Startups, September 3, 2026, https://socalstartups.io/companies/model-medicines-inc. Accessed September 28, 2026.
APA
SoCal.Startups. (2026). Model Medicines, Inc.: Funding & Investors. Retrieved September 28, 2026, from https://socalstartups.io/companies/model-medicines-inc
WIKIPEDIA (CITE WEB)
{{cite web |title=Model Medicines, Inc.: Funding & Investors |url=https://socalstartups.io/companies/model-medicines-inc |website=SoCal.Startups |access-date=September 28, 2026}}
🏷 Embed this badge

Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.

Model Medicines, Inc. featured on SoCal.Startups
HTML
<a href="https://socalstartups.io/companies/model-medicines-inc" target="_blank" rel="noopener"><img src="https://socalstartups.io/badge.svg" width="220" height="52" alt="Model Medicines, Inc. featured on SoCal.Startups" /></a>
MARKDOWN
[![Model Medicines, Inc. featured on SoCal.Startups](https://socalstartups.io/badge.svg)](https://socalstartups.io/companies/model-medicines-inc)